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Neuronal accumulation of UBB+1, a frameshift variant
of ubiquitin B, is a hallmark of Alzheimer’s disease
(AD). How UBB+1 contributes to neuronal dysfunc-
tion remains elusive. Here, we show that in brain
regions of AD patients with neurofibrillary tangles
UBB+1 co-exists with VMS1, the mitochondrion-spe-
cific component of the ubiquitin-proteasome system
(UPS). Expression of UBB+1 in yeast disturbs the
UPS, leading to mitochondrial stress and apoptosis.
Inhibiting UPS activity exacerbates while stimulating
UPS by the transcription activator Rpn4 reduces
UBB+1-triggered cytotoxicity. High levels of the
Rpn4 target protein Cdc48 and its cofactor Vms1
are sufficient to relieve programmed cell death. We
identified the UBB+1-induced enhancement of the
basic amino acids arginine, ornithine, and lysine
at mitochondria as a decisive toxic event, which
can be reversed by Cdc48/Vms1-mediated pro-
teolysis. The fact that AD-induced cellular dysfunc-
tions can be avoided by UPS activity at mitochon-
dria has potentially far-reaching pathophysiological
implications.
INTRODUCTION
UBB+1, a loss-of-function variant of ubiquitin B (UBB), accumu-
lates in neurofibrillary tangles, a pathological hallmark in Alz-
heimer’s disease (AD) (van Leeuwen et al., 1998). UBB+1 is trans-Celllated from an aberrant mRNA encoding a +1 frameshift protein
in which theC-terminal glycine residue required for ubiquitylation
is replaced by an extension of 20 amino acids (Dennissen
et al., 2010). The detrimental impact of UBB+1 has been studied
in neuronal cell cultures, transgenicmice, and yeast (De Vrij et al.,
2001; Fischer et al., 2009; Tank and True, 2009). UBB+1 is a
substrate for truncation, ubiquitylation, and proteasomal degra-
dation (Dennissen et al., 2011; Lindsten et al., 2002; van Tijn
et al., 2007, 2010). Whereas the ubiquitin-proteasome system
(UPS) can assure the degradation of low levels of UBB+1, higher
levels impair the UPS and subvert the homeostatic mechanisms
allowing for its elimination (Fischer et al., 2009; Lindsten et al.,
2002; van Tijn et al., 2007, 2010). At high levels, UBB+1 affects
mitochondrial dynamics and triggers neuronal cell death (De
Vrij et al., 2001; Tan et al., 2007) through as-yet elusive
mechanisms.
Yeast is an established model for studying programmed cell
death mechanisms that are often shared with animal cells,
including the contribution of caspases and mitochondrion-asso-
ciated cell death proteins, such as cytochrome c (Carmona-Gu-
tierrez et al., 2010). Yeast models have been used to explore cell
killing by neurotoxic proteins, such as Parkinson-disease-asso-
ciated a-synuclein, and the outcome could be successfully
translated to fly, worm, and murine disease models, as well as
to human disease (Braun et al., 2010; Bu¨ttner et al., 2013).
Driven by these premises, we established a yeast cell death
model for UBB+1-triggered neurotoxicity. Our findings revealed
that UBB+1 interfered with the UPS and triggered the perturba-
tion of themitochondrion-associated basic amino acid synthesis
executing cell death. The mitochondrion-associated UPS sub-
routine, depending on the AAA-ATPase Cdc48 and its co-factor
Vms1, strongly antagonized UBB+1 cytotoxicity. Since VMS1,Reports 10, 1557–1571, March 10, 2015 ª2015 The Authors 1557
Figure 1. Expression of UBB+1 in Yeast and Its Effect on UPS Activity
(A) Proteins were expressed for 1, 2, or 3 days and determined by immunoblotting of cell extracts using antibodies directed against the N-terminal FLAG-tag, or
the specific C terminus of UBB+1. Hexokinase (Hxk) was used as loading control. #, unspecific protein band; fl-UBB+1, full-length UBB+1; tUBB+1, truncated
UBB+1.
(B) The level of polyubiquitylated proteins and of UBB+1 in cell extracts was determined by immunoblotting using an antibody directed against ubiquitin. *Un-
characterized ubiquitin variant.
(C) Quantification of (B). The levels of polyubiquitylated proteins of cells transformed with vector controls were set to 100% in every experiment.
(D) Cellular level of ubiquitin-G76V-GFP upon UBB+1 expression. GFP fluorescence (relative fluorescence units, RFUs) was normalized to optical densities
(OD600).
Data: percentage change values (C) and mean values (D), respectively. Error bars: SE. p values: *p < 0.05, **p < 0.01. See Table S1 and Figure S1.the human homolog of yeast Vms1, co-exists with UBB+1 in
neurofibrillary tangles, these data imply a potential pivotal role
of the UPS at mitochondria in AD.
RESULTS
Expression of Human UBB+1 in Yeast Recapitulates
Hallmarks of UBB+1 in Neurons
To investigate whether the introduction of UBB+1 into yeast reca-
pitulates hallmarks of UBB+1 accumulation in neurons, we ex-
pressed monomeric ubiquitin B (UBB), UBB+1, as well as an
UBB+1 variant lacking two lysine residues (K29,48R) that are
important for its ubiquitylation. When expressing UBB, we de-
tected a discrete immunoreactive band at the size of monomeric
ubiquitin (9 kDa), and an immunoreactive smear across a wide
range of the immunoblot that corresponds to ubiquitylated pro-
teins (Figure 1A). This smear was not detectable upon transfor-
mation with UBB+1 or UBB+1-K29,48R, reflecting their loss of
function. Instead, UBB+1 or UBB+1-K29,48R were detectable1558 Cell Reports 10, 1557–1571, March 10, 2015 ª2015 The Authoras 12 and 9 kDa protein species (full-length and truncated
UBB+1; fl-UBB+1 and tUBB+1) that accumulated over time (Fig-
ures 1A, S1A, and S1B). In cells expressing UBB+1, a faint higher
molecular weight species corresponding to the size of monoubi-
quitylated fl-UBB+1 (21 kDa) appeared (Figure 1A, FLAG long
exposure, asterisks). Consistent with a role of lysines 29 and/or
48 in the ubiquitylation of UBB+1, this band was absent in cells
expressing UBB+1-K29,48R. These results suggest that in yeast
human UBB (but not UBB+1) can serve as a substrate for ubiqui-
tin ligases and that, like in neurons, UBB+1 is ubiquitylated and
truncated.
Next, we investigated whether UBB+1 expression results in
UPS impairment by means of three complementary assays: (1)
the measurement of polyubiquitylated endogenous proteins by
immunoblot; (2) the assessment of the abundance of transgenic
ubiquitin-G76V-GFP, which is a substrate of the ubiquitin-fusion
degradation pathway; and (3) an enzymatic assay designed to
quantify the chymotrypsin-like proteasomal activity. Cells ex-
pressing UBB+1 or UBB+1-K29,48R contained a higher level ofs
polyubiquitylated proteins than cells transformed with vector
controls (Figures 1B and 1C), suggesting decreased UPS-
dependent protein turnover. The steady-state levels of ubiqui-
tin-G76V-GFP were significantly increased upon expression of
UBB+1 or UBB+1-K29,48R (Figure 1D). In contrast, UBB+1 or
UBB+1-K29,48R expression did not reduce chymotrypsin-like
proteasomal activities (Figure S1C). These data suggest that,
in yeast like in neurons, UBB+1 expression impairs the UPS.
However, in yeast UBB+1 does neither directly affect the enzy-
matic activity of proteasomes, nor is its ubiquitylation essential
for UPS dysfunction.
UBB+1 Triggers Oxidative Stress and Programmed Cell
Death upon Protracted Expression
To assess its effects on the fitness of proliferating cells, we per-
formed growth assays on agar plates and in liquid cultures. As a
positive control of cytotoxicity, TDP-43, a causal factor for motor
neuron degeneration, was expressed. In sharp contrast with
TDP-43, UBB+1 and UBB+1-K29,48R failed to compromise the
growth of cells on agar plates (Figure 2A), and in liquid cultures
(Figure 2B), suggesting that UBB+1 is unable to kill proliferating
cells.
Next, we studied the effects of UBB+1 or UBB+1-K29,48R on
chronologically aged cultures. For this, the proportion of viable
cells capable of forming a colony (clonogenicity) on nutrient-
containing solid medium was studied at different time points
following UBB+1 or UBB+1-K29,48R expression. Consistent
with the growth assays, 16 hr (day 1) after UBB+1 or UBB+1-
K29,48R expression cells exhibited a similar clonogenic poten-
tial as did cells expressing vector controls (Figure 2C). In
contrast, we observed a 10% and 25% decrease in clono-
genic cell survival when expressing UBB+1 for 2 and 3 days,
respectively. Exogenously applied stressors, including acetate
and hydrogen peroxide, further enhanced the cytotoxicity of
prolonged UBB+1 expression (Figures S2A and S2B, left).
Upon both chronological aging and stress experiments,
UBB+1-K29,48R turned out to be slightly less cytotoxic as
compared to UBB+1 (Figures 2C, S2A, and S2B, left), suggest-
ing that ubiquitylated UBB+1 is slightly more cytotoxic than
UBB+1.
We next examined whether the UBB+1-induced loss of clono-
genicity correlated with the manifestation of oxidative stress,
which can be detected by the intracellular conversion of the
reactive oxygen species (ROS)-sensitive stain dihydroethidium
(DHE) to fluorescent ethidium. We observed indistinguish-
able low levels of oxidative stress after expressing UBB+1 or
UBB+1-K29,48R for 16 hr (day 1) (Figure 2D). At later time points,
the levels of oxidative stress progressively increased in all
cultures with chronological aging, and UBB+1-expressing cells
exhibited a mild but significant increase in oxidative stress as
compared to vector controls. Thus, upon UBB+1 expression
increased markers of oxidative stress coincided with decreased
clonogenic cell survival (cf. Figures 2C, 2D, and S2C). When
combined with protracted UBB+1 expression, acetate or
hydrogen peroxide exacerbated the signs of oxidative stress
(Figures S2A and S2B, right). As shown for clonogenic survival,
UBB+1-K29,48R demonstrated slightly decreased levels of
oxidative stress upon chronological aging or exogenouslyCellapplied stress as compared to UBB+1 (Figures 2D, S2A, and
S2B).
To determine the mode of cell death triggered by the expres-
sion of UBB+1 or UBB+1-K29,48R, we performed double staining
with Annexin V-FITC and propidium iodide (PI). Annexin V-FITC
labels externalized phosphatidylserine that appears on the sur-
face of apoptotic cells, whereas PI is a vital dye that stains cells
that have lost plasma membrane integrity during necrosis. Two
days after UBB+1 expression the frequencies of early apoptotic
(Annexin V-FITC+ PI), late apoptotic or secondary necrotic (An-
nexin V-FITC+ PI+), and necrotic cells (Annexin V-FITCPI+) were
increased, as compared with vector controls (Figures 2E and
S2D). Apoptosis induction by UBB+1 could be confirmed by
the terminal deoxynucleotidyl transferase dUTP nick-end label-
ing (TUNEL) that detects fragmentation of nuclear DNA (Figures
2F and S2E). Consistent with the results obtained from the
clonogenic survival and oxidative stress experiments, UBB+1-
K29,48R triggered cell death in a lower number of cells as
compared to UBB+1 (Figures 2E and 2F). Altogether, these re-
sults indicate that the protracted expression of UBB+1 can
induce apoptotic and necrotic killing of yeast cells, and that ubiq-
uitylated UBB+1 is a slightly better killer than UBB+1.
The UPS Capacity and the Ratio of Mutant to Wild-Type
Ubiquitin Determine UBB+1-Triggered Cytotoxicity
To investigate the putative contribution of dysfunctional UPS to
UBB+1-triggered cytotoxicity, wemeasured the cytotoxic poten-
tial of UBB+1 in the context of enhanced or suppressed UPS.
Since full knockout of genes coding for proteasomal subunits is
lethal, yeast strains bearing point mutations in one or two
proteasomal genes were employed (Heinemeyer et al., 1993).
The chymotrypsin-like proteasomal activity was reduced in
strains carrying mutant alleles in the proteasomal subunits Pre1
and Pre2 by >88% (Figure 3A). In these conditions of close-to-
complete proteasomal inactivation, significantly reduced clono-
genic cell survival was only observed in the pre1-1 and the
pre1-1/pre2-2 strains upon UBB+1 expression for day 1, and in
the pre1-1/pre2-2 strain upon UBB+1 expression for day 2 (Fig-
ures 3B and S3A), as compared towild-type strain. One explana-
tion for the increased UBB+1-triggered cytotoxicity would be that
UBB+1 accumulates in these strains due to impaired UBB+1
degradation. However, we could not observe increased steady-
state levels of UBB+1 in these strains (neither fl-UBB+1, nor
tUBB+1, nor ubiquitylated fl-UBB+1) (Figures S3D–S3F; data not
shown). Thus, although severe proteasomal inactivation can in-
crease UBB+1-triggered cell death, there is no strict correlation
between the loss of proteasomal capacity on the one hand, and
the increase in UBB+1-triggered cytotoxicity or the increase in
the steady-state levels of UBB+1 on the other hand.
Next, we measured UBB+1-induced cytotoxicity in knockout
strains lacking selective UPS genes, including (1) UBI4 encod-
ing ubiquitin (Finley et al., 1987), (2) RPN4 encoding a major
transcriptional UPS activator (Mannhaupt et al., 1999), (3)
UBR2 encoding the E3 ligase responsible for Rpn4 degradation
(Kruegel et al., 2011), (4) YUH1 encoding the ubiquitin protease
that cleaves fl-UBB+1 into tUBB+1 (Dennissen et al., 2011), and
(5) UBP6 encoding a deubiquitinase, which can be inhibited by
extended ubiquitin proteins (Krutauz et al., 2014). Only RPN4Reports 10, 1557–1571, March 10, 2015 ª2015 The Authors 1559
Figure 2. Cytotoxicity and Cell Death upon UBB+1 Expression
(A) Growth on solid media. Cultures were spotted in serial dilutions onto solid media inducing or repressing expression.
(B) Growth in liquid media. Left, growth curves. Right, cell densities during stationary phase.
(C) Yeast cells were evaluated for clonogenicity (colony forming units [CFUs]) at the indicated time points after inducing expression.
(D) Oxidative stress levels (DHE staining) were measured using a fluorescence plate reader at the indicated time points after inducing expression.
(E and F) Apoptosis and necrosis. (E) 2 days after inducing expression, yeast cells were measured for (early) apoptosis (Annexin V+/PI), necrosis (Annexin V/
PI+), and (late) apoptosis/secondary necrosis (Annexin V+/PI+). (F) TUNEL-positive cells are referred to be apoptotic.
Data: mean values (B–F). Error bars: SD (B), and SE (C–F), respectively. p values: *p < 0.05, **p < 0.01, ***p < 0.001. See Table S1 and Figure S2.deletion significantly impaired the chymotrypsin-like proteaso-
mal capacity of the cells (Figure 3C). Notably, upon comparable
fl-UBB+1 steady-state levels (Figures S3G and S3I), UBB+1-trig-
gered cytotoxicity was significantly increased in Dubi4 as
compared to Drpn4 upon both stressed und unstressed condi-
tions (Figures 3D and S3B), although the proteasomal capacity
was lower in Drpn4 as compared to Dubi4 (Figure 3C). These
data propose that the ratio of mutant ubiquitin (UBB+1) to1560 Cell Reports 10, 1557–1571, March 10, 2015 ª2015 The Authorwild-type ubiquitin (encoded by UBI4) is more relevant for
determining UBB+1-triggered cytotoxicity than the proteasomal
capacity.
Upon stressed conditions, UBB+1-triggered cytotoxicity was
markedly increased in Dyuh1 as compared to wild-type cells
upon comparable fl-UBB+1 steady-state levels (Figures 3D,
S3B, S3H, and S3I). These data suggest that UBB+1 truncation
is a putative protective event, for instance, as part of as
Figure 3. UBB+1-Triggered Cytotoxicity in Yeast Strains with Various UPS Capacities
(A) Cultures were grown in logarithmic phase in YPD at 30C and chymotrypsin-like activities were determined in proteasomal mutant strains. The relative
luminescence units (RLUs) obtained using wild-type cells were set to 100% in every experiment.
(B) Clonogenicity in proteasomal mutant strains 1 day after inducing expression. The CFUs obtained using cells expressing vector controls were set to 100% in
every experiment.
(C) Cultures were grown in logarithmic phase in YPD at 30C and chymotrypsin-like activities were determined in UPS knockout strains. The RLUs obtained using
wild-type cells were set to 100% in every experiment.
(D) Clonogenicity in UPS knockout strains 2 days after inducing expression following acetate treatment. The CFUs obtained using cells expressing vector controls
were set to 100% in every experiment.
(E) Cultures were grown in logarithmic phase in defined medium inducing expression of the transcription activator RPN4, and chymotrypsin-like proteasomal
activities were determined. The RLUs obtained using cells carrying vector controls were set to 100% in every experiment.
(F) Clonogenicity of UBB+1-expressing cultures in strains with endogenous (vector control) and elevated levels of Rpn4 (Rpn4), respectively. Clonogenicity was
determined 1 day after inducing expression followed by acetate treatment. The CFUs obtained using cells with endogenous and elevated levels of Rpn4,
respectively, but lacking UBB+1, were set to 100% in every experiment (not shown).
Data: percentage change values. Error bars: SE. p values: xp < 0.1, *p < 0.05, **p < 0.01, ***p < 0.001. See Table S1 and Figure S3.mechanism to degrade excessive UBB+1. In Dubp6 as
compared to wild-type cells UBB+1-triggered cytotoxicity was
unaltered upon comparable fl-UBB+1 steady-state levels (Fig-
ures 3D, S3B, S3G, and S3I), suggesting that Ubp6 activity is
not protective against the accumulation of the extended ubiqui-
tin UBB+1.
UBB+1-triggered cytotoxicity was significantly relieved in
Dubr2 cells upon stressed conditions (Figures 3D and S3B), in
which Rpn4 is stabilized and consequently the UPS activity is
increased (Kruegel et al., 2011). Consistently, Rpn4 expression,
which also leads to increased UPS activities (Figure 3E), was
protective for UBB+1-expressing wild-type cells (Figures 3F
and S3C) but not for cells lacking UBI4 (Figure S3C). In both
cases, the protective effect cannot be explained by decreased
steady-state levels of UBB+1 (Figures S3G and S3I–S3K). These
data show that increasing UPS capacity is protective for UBB+1-
expressing cells, but not by affecting the turnover of UBB+1 itself
but rather by interrupting the lethal signaling cascade triggered
by UBB+1.CellUBB+1 Causes Lethal Mitochondrial Dysfunction
Oxidative stress and mitochondrial impairment are hallmarks of
neurotoxin-elicited death in yeast and neurons (Braun, 2012; De-
battisti and Scorrano, 2013). Therefore, we analyzed whether
oxidative stress, which occurred starting by day 2 of UBB+1
expression (Figure 4A), correlated with mitochondrial impair-
ment. Two days after inducing UBB+1 expression, the mitochon-
drial network was fragmented in both UBB+1-expressing cells,
as well as in cells carrying vector controls (data not shown),
which is typical for stationary phase cultures. However, after
shifting these cultures to fresh growth medium (which represses
UBB+1 expression) the recovery of the mitochondrial network
was significantly compromised in cultures transformed with
UBB+1-encoding constructs as compared with vector controls
(Figures 4B and S4A). These data suggest that mitochondrial
and oxidative stresses coincide in cells expressing UBB+1.
We further tested for mitochondrial impairment by measuring
the cellular oxygen consumption, the mitochondrial membrane
potential, and the ATP levels in cells expressing UBB+1 forReports 10, 1557–1571, March 10, 2015 ª2015 The Authors 1561
Figure 4. Pivotal Mitochondrial Impairment upon UBB+1 Expression
(A) Oxidative stress levels were measured by flow cytometry 2 days after inducing expression.
(B) Mitochondrial fragmentation. UBB+1 and RFP fused with a mitochondrial targeting sequence were expressed. 2 days after induction, cultures were shifted to
fresh media repressing expression, and after 3 hr the proportion of cells with fragmented mitochondria was quantified.
(C–E) Cellular oxygen consumption (C), mitochondrial membrane potential (D), and cellular ATP levels (E) were determined 2 and 3 days after inducing UBB+1
expression. The oxygen consumption (C), mitochondrial membrane potential (D), and ATP levels (E) measured using cells carrying vector controls were set to
100% in every experiment.
(F and G) Protein alterations in crude mitochondria. UBB+1 was expressed for 24 hr and crude mitochondria were isolated by differential centrifugation. (F)
Immunoblot demonstrating the steady-state levels of Rip1, cytochrome c (Cyt. c), and the mitochondrial outer membrane protein Por1 as loading control. (G)
Quantification of (F). The immunoreactive signals obtained using cells carrying vector controls were set to 100% in every strain and experiment.
(H and I) UBB+1-triggered cytotoxicity in strains deleted from genes encoding mitochondrial cell death (H), and ER-associated proteins (I), respectively. Clo-
nogenicity was determined 2 days after inducing expression followed by acetate treatment. The CFUs obtained using cells carrying vector controls were set to
100% in every experiment.
Data: mean values (A and B), and percentage change values (C–E, G–I), respectively. Error bars: SE. p values: *p% 0.05, **p < 0.01. See Table S1 and Figure S4.days 2 and 3. Whereas the cellular oxygen consumption and
mitochondrial membrane potential were significantly increased
by day 3 in (surviving) cells expressing UBB+1 (Figures 4C and
4D), the cellular ATP levels were significantly decreased by
days 2 and 3 (Figure 4E). These data hint at hyperactive mito-
chondria, which are incapable to prevent a metabolic crisis in
UBB+1-expressing cells.
In yeast, alterations in the cytochrome bc1 complex of the
mitochondrial respiratory chain may contribute to the loss of1562 Cell Reports 10, 1557–1571, March 10, 2015 ª2015 The Authorrespiratory capacity and the production of lethal ROS (Diaz
et al., 2012; Eisenberg et al., 2007). For instance, loss of the
Rieske iron-sulfur protein Rip1, a key component of the cyto-
chrome bc1 complex, results in increased ROS generation
and mitochondrial dysfunction (Diaz et al., 2012). Indeed,
the cellular level of Rip1 was markedly decreased by days 2
and 3 upon UBB+1 expression as compared with vector con-
trols (Figures S4B and S4C). Consistently, Rip1 and cyto-
chrome c were depleted in the mitochondrial fraction ofs
UBB+1-expressing cells (Figures 4F and 4G). These data
further hint at a major UBB+1-induced mitochondrial dysfunc-
tion, in which the respiratory chain is impaired (depletion of
Rip1 and cytochrome c), leading to the production of ROS
(for which cellular oxygen is needed), and the decline of
cellular ATP levels.
Hyperpolarization of mitochondria may precede mitochon-
drion-dependent yeast death (Eisenberg et al., 2007); therefore,
we expressed UBB+1 in strains deleted for genes encoding a
range of mitochondrial cell death proteins, including the yeast
BH3-only protein (Ybh3) that translocates to mitochondria to
mediate their permeabilization, and several potentially cytotoxic
proteins that can be released from mitochondria such as
apoptosis-inducing factor 1 (Aif1), endonuclease G (Nuc1), and
the two cytochrome c isoforms (Cyc1, Cyc7). Deletion of NUC1
resulted in a paradoxical increase in UBB+1-triggered cytotox-
icity, and loss of Ybh3 did not have any effect upon both stressed
and unstressed conditions (Figures 4H and S4D). In contrast,
UBB+1-mediated cytotoxicity was significantly decreased in
strains depleted from isoform 2 of cytochrome c (Dcyc7) upon
stressed conditions (Figures 4H and S4D). The steady-state
levels of UBB+1 were not decreased in the Dcyc7 as compared
to wild-type strain (Figure S4F), and this strain maintained a
normal state of respiratory competence (presumably due to the
presence of the cytochrome c isoform 1 Cyc1) (Figure S4I),
excluding trivial explanations for the cytoprotective action of
Dcyc7. Thus, our data suggest the implication of mitochondria
in UBB+1-triggered cell death.
Next, we tested for a possible role of the unfolded protein
response (UPR) and the ER in UBB+1-triggered cytotoxicity
and expressed UBB+1 for 2 days in cells lacking the UPR kinase
Ire1 and its downstream target Hac1, as well as in cells lacking
the ER cell death protease Kex1 (which executes cell death in
which mitochondria play a pivotal role [Hauptmann and Lehle,
2008]). Upon stress, UBB+1-triggered cytotoxicity was relieved
in Dire1 and Dkex1 but not in Dhac1 cells (Figures 4I and S4E),
under conditions where the steady-state levels of UBB+1 were
comparable (Figures S4G and S4H). These data suggest for an
implication of the ER in UBB+1-triggered cytotoxicity, but, due
to the lack of rescue in the Dhac1 cells, a critical involvement
of the UPR is unlikely.
Perturbation of Basic Amino Acid Synthesis at
Mitochondria Is a Decisive Toxic Event upon UBB+1
Accumulation
Next, we performed quantitative proteomic analyses of crude
mitochondria after ‘‘stable isotope labeling by amino acids in
cell culture’’ (SILAC). This approach led to the identification of
16 proteins whose abundance was significantly altered
(increased for ten or decreased for six proteins) upon UBB+1
expression (Figure 5A; Table S2). Among the proteins with estab-
lished mitochondrial localization, three were enzymes partici-
pating in amino acid metabolism, namely, Put1 (involved in
proline degradation), Arg5,6, and Arg8 (involved in arginine
and ornithine biosynthesis). In addition, UBB+1 induced the
accumulation of the cytosolic enzyme Lys1 (involved in lysine
biosynthesis), an increase in the motor protein Myo3 and the
(putative) peroxisomal proteins Gpd1 and Str3, in crude mito-Cellchondria. Upon acetate stress, deletion of the ARG5,6, ARG8,
and the LYS1 genes restored the clonogenic potential of
UBB+1-expressing cells, whereas the deletion of all other
genes had no effect (Figures 5B and S5A). These data point to
a hitherto unexpected involvement of the biosynthesis of basic
amino acids (arginine, ornithine, and lysine) in UBB+1-triggered
cytotoxicity.
To challenge this hypothesis, we measured the cellular
steady-state levels of arginine, ornithine, and lysine in cultures
expressing UBB+1 (Figure 5C). Indeed, we observed a marked
increase in the cellular levels of all three basic amino acids, in
particular, ornithine, upon UBB+1 accumulation. To weigh the
contribution of arginine and ornithine (as opposed to their meta-
bolic intermediates) to UBB+1 cytotoxicity, we measured ROS
production upon UBB+1 expression in strains depleted from
the arginine and ornithine biosynthetic enzymes (Figure 5D).
Depletion of all enzymes operating upstream of cytosolic orni-
thine (Arg2, Arg5,6, Arg7, and Ort1) significantly relieved
UBB+1-triggered cytotoxicity both in unstressed and acetate-
stressed conditions (Figures 5E and S5B). In contrast, none of
the enzymes downstream of cytosolic ornithine (Arg3, Arg1,
and Arg4, which are needed for the conversion of ornithine into
arginine) were required for the cytotoxic action of UBB+1.
Notably, all tested enzymes operating upstream of cytosolic
ornithine are mitochondrion-associated (Ljungdahl and Dai-
gnan-Fornier, 2012). Therefore, we concluded that UBB+1 trig-
gers the mitochondrion-associated biosynthesis of ornithine,
leading to increased cytosolic levels of ornithine (and its product
arginine). This plays a decisive role in executing UBB+1-triggered
cell death.
If this model is true, increasing cytosolic levels of either orni-
thine or arginine (which can easily be interconverted into each
other) should recover the cytotoxic effect of UBB+1 in strains
with interrupted mitochondrion-associated biosynthesis of orni-
thine. Therefore, we measured UBB+1-triggered cell death in the
strain depleted for the mitochondrial protein Ort1 in growth me-
dia with increasing concentrations of arginine and ornithine,
respectively. It turned out that Dort1 cells were not able to effi-
ciently uptake ornithine from the growth media, because the se-
vere growth deficit of the Dort1 strain in growth media lacking
arginine could not be relieved by increasing concentrations of
ornithine in the growth media (data not shown). In contrast,
Dort1 cells grew well in the presence of arginine in growth media
lacking ornithine (data not shown), demonstrating the efficient
cellular uptake of arginine. As expected, yeast cells lacking
Ort1 were protected fromUBB+1-triggered cell death uponmod-
erate concentrations of arginine (30 and 50 mg/l) in the growth
media (Figure 5F). In contrast, elevated concentrations of argi-
nine in the growth media (150 and 300 mg/l) recovered the cyto-
toxic effect of UBB+1 (Figure 5F), substantiating the decisive role
of increased cellular levels of arginine (and cytosolic ornithine) in
executing UBB+1-triggered cell death.
In order to address the role of cellular levels of lysine, we
measured UBB+1-triggered cell death in the strain depleted
from Lys1 in growth media with increasing concentrations of
lysine. Whereas deletion of LYS1 relieved UBB+1-triggered cyto-
toxicity as compared to wild-type strain (Figure 5B), increasing
the lysine concentrations did not promote cytotoxicity in theReports 10, 1557–1571, March 10, 2015 ª2015 The Authors 1563
Figure 5. Perturbation of Basic Amino Acid Synthesis upon UBB+1 Expression
(A) Protein alterations in crude mitochondria were quantified by SILAC in two independent experiments. Changes are shown that were significant in both
experiments.
(B) UBB+1-triggered cytotoxicity in strains deleted from genes encoding proteins accumulating in crudemitochondria upon UBB+1 expression. Clonogenicity was
determined 2 days after inducing expression followed by acetate treatment. The CFUs obtained using cells carrying vector controls were set to 100% in every
experiment.
(C) Basic amino acids were isolated from cultures expressing UBB+1 or vector controls, respectively. The mean values of amino acids from cells carrying vector
controls were set to 1.0 for every amino acid.
(legend continued on next page)
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Dlys1 strain (Figure 5G). Thus, in contrast to arginine/ornithine
the cellular lysine level appears to be negligible in accelerating
UBB+1-triggered cell death.
Cdc48/Vms1-Stimulated Mitochondrial UPS Protects
from UBB+1-Triggered Cytotoxicity
The aforementioned data incriminate mitochondria and the
UPS in the execution of UBB+1-triggered cytotoxicity, notably
because of the protective impact of the removal of mitochon-
drial enzymes involved in basic amino acid synthesis and the
overexpression of the transcriptional UPS activator Rpn4.
Among the known Rpn4 targets are the conserved AAA-ATPase
Cdc48 and its cofactor Npl4 (Bosis et al., 2010). Cdc48 and
Npl4 are involved in the UPS, and determined by their cofactor
Vms1, regulate mitochondrion-associated protein degradation
(Heo et al., 2010). Driven by these premises, we evaluated the
involvement of the Cdc48/Vms1/Npl4-dependent UPS pathway
to UBB+1-triggered cytotoxicity. For this, we measured UBB+1-
triggered cytotoxicity in normal and acetate-stressed conditions
in strains expressing increased levels of wild-type Cdc48 or the
pro-apoptotic Cdc48-S565G variant (Madeo et al., 1997), which
is characterized by decreased Vms1 binding and mitochon-
drion-associated degradation (Heo et al., 2010). We also deter-
mined the cytotoxicity of UBB+1 in strains depleted from the
Cdc48 cofactors Npl4 and Vms1, or overexpressing Vms1.
UBB+1-triggered cytotoxicity was markedly attenuated in cul-
tures expressing increased levels of wild-type Cdc48, as
compared to cells expressing Cdc48-S565G or controls with
endogenous Cdc48 only (Figures 6A and S6A). UBB+1-triggered
cytotoxicity was significantly increased in cultures depleted
from Npl4 under non-stressed conditions (Figures 6B and
S6B). Depletion of Vms1 resulted in a marked elevation in cyto-
toxicity upon stress (Figures 6C and S6C), while overexpression
of Vms1 significantly protected against UBB+1 upon acetate
stress, as measured by the clonogenic approach (Figures 6D
and S6D). High levels of Vms1 also protected from cell
death and oxidative stress induced by UBB+1 expression (Fig-
ures 6E and 6F). Notably, high amounts of Cdc48 and Cdc48-
S565G resulted in markedly decreased steady-state levels of
UBB+1 (Figures S6E and S6F), whereas neither the deletion of
VMS1, nor its overexpression had an effect on the cellular
UBB+1 amounts (Figures S6G–S6J). These data point to a
protective role of Vms1, which is independent from UBB+1
degradation, potentially by improving the quality control at mito-
chondria. In contrast, the beneficial role of high amounts of
Cdc48 could be due to both increased Vms1-independent
UBB+1 degradation and improved Vms1-dependent mitochon-
drial quality control.(D) Arginine and ornithine biosynthetic pathway inS. cerevisiae. Green: deletion of
prevent (red) from UBB+1-triggered oxidative stress, respectively (see E and Figu
(E) Oxidative stress in strainswith disrupted arginine/ornithine biosynthesis wasm
The oxidative stress levels obtained using cells carrying vector controls were se
(F) Cell death in strains with disrupted arginine/ornithine biosynthesis and increas
UBB+1 expression. The proportion of dead cells carrying vector controls was se
(G) Cell death in strains with disrupted lysine biosynthesis and increased level
expression. The proportion of dead cells carrying vector controls was set to 100
Data: percentage change values (B and E–G) and mean values (C), respectively. E
S1, S2, and S4 and Figure S5.
CellIn order to addresswhether elevated Vms1 levels prevent from
UBB+1-triggered mitochondrial impairment, we measured the
cellular oxygen consumption, the mitochondrial membrane po-
tential, and the cellular ATP levels in cells expressing UBB+1
upon endogenous or elevated amounts of Vms1 (Figures 6G–
6I). Whereas the cellular oxygen consumption and the mitochon-
drial membrane potential were significantly decreased by day 3
and days 2 and 3, respectively, cellular ATP levels were signifi-
cantly increased by day 2 upon high amounts of Vms1. In other
words, high amounts of Vms1 reverted the mitochondrial dam-
age induced by high levels of UBB+1 (see Figures 4C–4E).
In a next step, we used SILAC technology to comparatively
assess alterations of the mitochondrial proteome between
UBB+1-expressing cells with endogenous and high levels of
Vms1 (Figure 6J; Table S3). We observed that among the 16
proteins whose abundance levels were altered by UBB+1 as
compared with the vector control (Figure 5A; Table S2), ten
were no more altered upon expression of both UBB+1 and
Vms1 (Figure 6J, blue-labeled proteins). Among these ten pro-
teins, which were particularly stringently associated with the
cytopathic activity of UBB+1, the basic amino acid synthesis en-
zymes Arg5,6, Arg8, and Lys1 were significantly decreased in
UBB+1-expressing cells upon high levels of Vms1, as compared
to endogenous Vms1 levels. Consistently, Vms1 overexpression
blunted the UBB+1-mediated increase in the steady-state levels
of arginine, ornithine, and lysine (Figure 6K, see Figure 5C).
These data point to a pivotal role of the Vms1-dependent mito-
chondrial UPS activity in avoiding the UBB+1-triggered lethal
overproduction of basic amino acids.
VMS1 Co-exists with tau and UBB+1 in Hippocampal
Neurons from AD Patients
The hippocampus is severely affected during AD progression.
Pathological hallmarks include intracellular neurofibrillary tan-
gles comprising aberrant forms of the microtubule-associated
protein tau, UBB+1, and the mitochondrial outer membrane
voltage-dependent anion channel 1 (VDAC1) (Reddy, 2013; van
Leeuwen et al., 1998). Immunohistochemistry revealed expres-
sion of VMS1, the human homolog of yeast Vms1, in pyramidal
cells within the hippocampi from AD patients and aged non-
demented controls (Figure 7A, all arrows; Tables S5 and S6).
VMS1 stained structures reminiscent of tau pathology, including
tangle-like (yellow arrows) and neuropil thread-like structures
(blue arrows), as well as other cellular staining patterns (green
arrows), were observed in samples from AD patients, and
aged non-demented controls with tau pathology. We also
observed these tangle-like and thread-like staining patterns
when analyzing the sections for aberrant tau, UBB+1, andgenes encoding these enzymes does significantly prevent (green) and does not
re S5B); Black: no data.
easured 2 days after inducing UBB+1 expression followed by acetate treatment.
t to 100% in every experiment.
ed levels of arginine in the growth media was measured 2 days after inducing
t to 100% in every experiment.
s of lysine in the growth media was measured 2 days after inducing UBB+1
% in every experiment.
rror bars: SE. p values: xp < 0.1, *p < 0.05, **p < 0.01, ***p < 0.001. See Tables
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Figure 6. Role of Cdc48/Npl4/Vms1 Complex in UBB+1-Triggered Cytotoxicity
(A–C) UBB+1 was expressed in strains with elevated levels of Cdc48 or Cdc48-S565G (A) and strains deleted for NPL4 (B) and VMS1 (C). Clonogenicity was
determined 2 days after inducing expression before (B) and after acetate stress (A and C). The CFUs obtained using cells carrying vector controls were set to
100% in every experiment.
(D) Clonogenicity of UBB+1-expressing cultures in strains with endogenous (vector control) and elevated levels of Vms1 (Vms1), respectively. Clonogenicity was
determined 2 days after inducing expression followed by acetate treatment. The CFUs obtained using cells with endogenous and elevated levels of Vms1,
respectively, but lacking UBB+1, were set to 100% in every experiment (not shown).
(E and F) Cell death and oxidative stress was measured 1, 2, and 3 days after inducing expression of UBB+1 and/or Vms1.
(legend continued on next page)
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Figure 7. VMS1 Co-existence with Aberrant tau, UBB+1, or VDAC1 in Hippocampi of AD Patients
(A) VMS1 staining in AD patient and non-demented control.
(B) Principle of the staining of consecutive sections from the hippocampus of an AD patient shown in (C) and (D).
(C) Co-existence of aberrant tau (MC1) and VMS1.
(D) Co-existence of UBB+1 (Ubi2a), VMS1, and VDAC1.
See Figure S7 and Tables S5 and S6.VDAC1 (Figure S7). Immunohistochemistry of consecutive
paraffin sections from the hippocampi of AD patients (Figure 7B)
confirmed the identification of pyramidal cells with intracellular(G–I) UBB+1was expressed inwild-type strain with endogenous (vector ctrl) and in
membrane potential (H), and cellular ATP levels (I) were determined 2 and 3 d
membrane potential (H), and ATP levels (I) measured using cells with endogenou
(J) Protein alterations in crude mitochondria upon Vms1 expression. Mitochond
endogenous levels of Vms1, respectively. Protein alterations were quantified by
nificant in both experiments. Blue-labeled proteins are inversely regulated as co
(K) Cellular levels of basic amino acids upon Vms1 expression. Basic amino acids
control) or increased levels of Vms1 (Vms1), respectively. Themean values of amin
acid.
Data: percentage change values (A–D, G–I) andmean values (E, F, K), respectively
S1, S3, and S4 and Figure S6.
Celltangle-like structures, which co-stained for aberrant tau and
VMS1 (Figure 7C, violet arrows), and for UBB+1, VMS1, and
VDAC1 (Figure 7D, orange arrows). These data suggest thatcreased levels of Vms1 (Vms1). Cellular oxygen consumption (G), mitochondrial
ays after inducing expression. The oxygen consumption (G), mitochondrial
s Vms1 were set to 100% in every experiment.
ria were isolated from cultures expressing UBB+1 in cells with increased or
SILAC in two independent experiments. Changes were shown that were sig-
mpared to Figure 5A.
were isolated from cultures expressing UBB+1 in cells with endogenous (vector
o acids from cells with endogenous Vms1 levels were set to 1.0 for every amino
. Error bars: SE. p values: xp < 0.1, *p < 0.05, **p < 0.01, ***p < 0.001. See Tables
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VMS1 is a component of neurofibrillary tangles comprising aber-
rant tau, UBB+1, and VDAC1, underscoring a potential role of the
Cdc48/VMS1 complex in UBB+1-mediated AD progression.
DISCUSSION
We established a yeast model for dissecting cell death mecha-
nisms triggered by UBB+1, in which mitochondria play a pivotal
role in the execution of cell death (see the Supplemental Discus-
sion). UBB+1 triggers neuronal apoptosis accompanied by
reduced mitochondrial movement (Tan et al., 2007), and mito-
chondrial impairment likely contributes to AD (Rodolfo et al.,
2010). Thus, our yeast model corroborates features of
cell-death-relevant mitochondrion dysfunctions found in AD
neurons.
Yeast strains expressing UBB+1 accumulated the basic amino
acids arginine, ornithine, and lysine. Deletion of mitochondrion-
associated enzymes involved in their synthesis abolished
UBB+1-triggered cell killing, which could be recovered by
increasing concentrations of arginine in the growth media. The
accumulation of basic amino acids may trigger mitochondrial
damage and cell death in mammalian cells and in yeast (Almeida
et al., 2007; Biczo´ et al., 2011). For instance, increased produc-
tion of nitric oxide from arginine executes yeast apoptosis (Al-
meida et al., 2007) and increased levels of polyamines, which
are produced from ornithine, may impair neuronal ion channel
activities (Inoue et al., 2013). The levels of arginine, ornithine,
and/or their polyamine products were altered in aged human
brains and in brains from AD patients (Inoue et al., 2013; Liu
et al., 2014; Rushaidhi et al., 2012). The results of these studies
are controversial, and it remains not yet clear whether the
observed alterations are cause or consequence of AD. Despite
that, our data suggest that perturbed basic amino
acid synthesis is a decisive event triggering mitochondrion-
dependent cell death uponUBB+1 accumulation in yeast. Further
studies aiming at analyzing the role of arginine/ornithine meta-
bolism during aging or AD progression should consider a poten-
tial pivotal contribution of UPS and mitochondrial dysfunctions.
We observed that UBB+1 accumulation impaired the UPS, and
that the UPS activity, in turn, determined UBB+1 cytotoxicity.
Yeast cultures that were depleted from ubiquitin (Dubi4) were
highly vulnerable to UBB+1. In contrast, yeast cultures in which
the UPS was stimulated by the transcriptional activator Rpn4
were insensitive to UBB+1, but not in cells lacking the ubiquitin
gene UBI4. Extended ubiquitin variants have been proposed to
be specific inhibitors of the deubiquitinase Ubp6 in yeast (Kru-
tauz et al., 2014). Since the UBB+1-triggered cytotoxicity was un-
altered in a strain deleted for UBP6 as compared to wild-type
strain, our data suggest that the lethal effect of the extended
ubiquitin UBB+1 does not essentially depend on Ubp6. It is
tempting to speculate that the ratio of mutant (UBB+1) to wild-
type ubiquitin determines UBB+1-triggered cytotoxicity with
UBB+1 as a competitive inhibitor of wild-type ubiquitin, affecting
numerous ubiquitin-regulated cellular processes.
We established that elevated amounts of Cdc48 or its cofactor
Vms1 conferred tolerance against UBB+1 expression. More spe-
cifically, Vms1 overexpression relieved the UBB+1-triggered
mitochondrial damage and accumulation of the basic amino1568 Cell Reports 10, 1557–1571, March 10, 2015 ª2015 The Authoracids arginine, ornithine, and lysine. The Cdc48/Vms1 complex
enables the degradation of mitochondrion-associated proteins
(Heo et al., 2010). Whereas under normal conditions, this com-
plex is predominantly cytosolic, Vms1 recruits Cdc48 to the
mitochondrial outer membrane upon stress, presumably with
the scope of improving the local quality of proteins. Our data
suggest that Cdc48/Vms1-mediated processes can prevent
the UBB+1-triggered lethal derangement of mitochondria. In
one possible scenario, Cdc48/Vms1 might remove protein junk
from the mitochondrial outer membrane. Alternatively, Cdc48/
Vms1 might specifically prevent the accumulation of arginine,
ornithine, and lysine, through regulation of the turnover of the
enzymes Arg5,6, Arg8, and Lys1, which are pivotal for their syn-
thesis. Whereas the activity of the cytoplasmic enzyme Lys1
could be regulated by its degradation, the activities of the mito-
chondrion-associated Arg5,6 and Arg8 could be controlled by
preventing their import into mitochondria via ubiquitylation and
proteasomal degradation. Lys1, Arg5,6, and Arg8 are known tar-
gets for ubiquitylation (Xu et al., 2009), and the UPS regulates the
import of mitochondrial intermembrane space proteins (Bragos-
zewski et al., 2013; Harbauer et al., 2014). It is tempting to
speculate for a UPS-dependent regulation of the import of the
mitochondrial matrix proteins Arg5,6 and Arg8. Further studies
are needed to address the influence of UPS (dys)function on
the turnover of these and other mitochondrial proteins. This is
important because recent studies demonstrated that UPS
dysfunction can lead tomitochondrial dysfunction and vice versa
(Livnat-Levanon et al., 2014; Maharjan et al., 2014; Segref et al.,
2014), and our data revealed the unexpected link between
UBB+1-triggered UPS dysfunction and the accumulation of func-
tional enzymes in the mitochondrial matrix leading to potentially
cytotoxic accumulation of basic amino acids.
Human VMS1 and mitochondrial VDAC1 co-existed with
UBB+1 in neurofibrillary tangles of AD patients and aged non-
demented controls with tau pathology. UBB+1 accumulates
and the number of neurofibrillary tangles and damaged mito-
chondria markedly increase during AD progression (Dennissen
et al., 2010; Rodolfo et al., 2010). We propose that VMS1-depen-
dent mitochondrial quality control might retard the AD-associ-
ated neuronal dysfunction, which is elicited by the accumulation
of both aberrant tau and UBB+1.
EXPERIMENTAL PROCEDURES
Yeast Strains and Growth Conditions
Yeast expression constructs, strains, and growth conditions were described in
the Supplemental Experimental Procedures. Gene expression was under the
control of galactose-regulated promoters. For stressing cells, cultures were
treated for 4 hr with acetate. For stable isotope labeling (SILAC), cells express-
ing vector controls, UBB+1, or UBB+1 and Vms1 were grown in media supple-
mented either with Lys0 and Arg0 (normal isotopes), or with Lys4 and Arg6, or
with Lys8 and Arg10 (heavy isotopes, Silantes).
Measuring Cytotoxicity Based on Growth and Clonogenicity
Assays were performed as described in the Supplemental Experimental
Procedures. Briefly, growth deficits upon expression of proteins of interest
on solid or liquid media, as compared to vector controls, suggest for cyto-
toxic effects of these proteins on (growing) yeast cells. For clonogenic as-
says, 500 cells from liquid yeast cultures expressing proteins of interest
or vector controls, respectively, were plated on agar plates, on whichs
expression is repressed. The number of colonies (colony forming units
[CFUs]) formed after 2 days of incubation correlates with the fitness of
the culture.
Measurement of Oxidative Stress, Cell Death, Apoptosis, and
Necrosis
Oxidative stress was determined by measuring the conversion of dihydroethi-
dium (DHE, Sigma-Aldrich) to the red fluorescent ethidium applying a fluores-
cence plate reader or a flow cytometer. Cell death was measured by the
incorporation of the ‘‘vital dye’’ propidium iodide (PI, Sigma-Aldrich) in cells
that have lost their plasmamembrane integrity using a flow cytometer. Annexin
V/PI co-staining (Annexin V-FLUOS Staining Kit, Roche Applied Science) for
discriminating early and late apoptosis, as well as necrosis, and terminal deox-
ynucleotidyl transferase dUTP nick end labeling (TUNEL) for measuring
apoptosis (In Situ Cell Death Detection Kit, Roche Applied Science) were per-
formed by flow cytometry. See the Supplemental Experimental Procedures for
details.
Measurement of Cellular Oxygen Consumption, Mitochondrial
Membrane Potential, and Cellular ATP Levels
Oxygen consumption of stationary yeast cultures was analyzed using the Fire-
Sting optical oxygen sensor system (Pyro Science). The decrease of the oxy-
gen concentration over time in yeast cultures was determined. Mitochondrial
membrane potential was assessed with flow cytometry after staining cells
with tetramethylrhodamine methyl ester (TMRM, Molecular Probes, Life Tech-
nologies), a fluorescent dye that accumulates within mitochondria dependent
on their membrane potential. To determine the ATP level of yeast cultures,
intracellular metabolites were obtained using hot ethanol extraction. ATP
was measured using the ATP Determination Kit (Molecular Probes, Life Tech-
nologies). This assay is based on an ATP-dependent reaction of recombinant
firefly luciferase, which induces bioluminescence of its substrate D-luciferin
and is directly correlated with the ATP content. All data were normalized to
the number of living cells within the samples. See the Supplemental Experi-
mental Procedures for details.
Measurement of UPS Activities
For determining the level of polyubiquitylated proteins in cellular extracts, im-
munoblots of cellular extracts were incubated with an ubiquitin-specific anti-
body and immunosignals were quantified with ImageJ 1.47 m. For measuring
the turnover of UPS substrates, the ubiquitin-fusion protein ubiquitin-G76V-
GFPwas co-expressedwith UBB+1 or vector controls. GFP fluorescence (rela-
tive fluorescence units [RFUs]) and optical densities (OD600) were determined
using the FLUOstar Omega plate reader. RFU was normalized to OD600, in or-
der to determine the level of ubiquitin-GFP fusion proteins per culture. Mea-
surement of chymotrypsin-like proteasomal activities were performed using
the FLUOstar Omega plate reader, applying the luminescence-based Protea-
some-Glo Cell-Based Assay (Promega). See the Supplemental Experimental
Procedures for details.
Generation of Cell Extracts, SDS-PAGE, and Immunoblot Analyses
Yeast cultures were incubated in expression media (SCGal) for the indicated
time points. Cell extracts were generated by pre-treating yeast pellets in
NaOH followed by heating in SDS lysis buffer. Protein extracts were separated
on Tricine-SDS polyacrylamide gels, transferred on PVDF membranes, and
incubated with primary and secondary antibodies coupled to horseradish
peroxidase. Immunodetection was done using luminol. Membranes were digi-
tized in an ImageQuant LAS 4000 (GE Healthcare). Images were processed
with Adobe Photoshop CS6. Immunoblot quantification was done with the
gel analysis method in ImageJ 1.47 m. See the Supplemental Experimental
Procedures for details.
Mass Spectrometry
Crude mitochondrial extracts were taken up in SDS lysis buffer, thawed,
reduced with DTT, and alkylated using iodoacetamide (Sigma-Aldrich). Protein
mixtures were separated by SDS-PAGE using Bis-Tris gels (NuPAGE, Invitro-
gen). The gel lanes were cut into slices, which were in-gel digested with trypsin
(Promega), and the resulting peptide mixtures were processed on STAGE tips.CellMass spectrometry was performed on a LTQ Orbitrap XL mass spectrometer
(Thermo Fisher Scientific) coupled to an Eksigent NanoLC-ultra. See the Sup-
plemental Experimental Procedures for details.
Metabolomics
For extraction of metabolites cultures were harvested by filtration, washed
with ddH2O, and quenched in liquid nitrogen. Metabolites were extracted by
acid extraction using trichloroacetic acid and by hot ethanol extraction.
Extracts obtained from uniformly 13C-labeled yeast cells served as internal
standard. Metabolites were determined using ion pair reversed-phase liquid
chromatography coupled to negative electro spray high-resolution mass
spectrometry (IP-RP-LC/HRMS). LC/MS measurements were normalized to
the total number of cells of each sample. See the Supplemental Experimental
Procedures for details.
Immunohistochemistry
Experiments with human materials were in accordance with the local ethical
committees at the Universities of Bayreuth (Germany) and Maastricht (the
Netherlands). Postmortem tissues of hippocampi from AD patients and non-
demented controls were obtained from the Netherlands Brain Bank (Table
S6) as paraffin sections. For immunohistochemistry, sections were deparaffi-
nated, incubated with primary antibodies against the indicated proteins, and
with biotin-coupled secondary antibodies followed by the avidin-biotin-perox-
idase complex. Immunodetection was performed by the colorimetric reaction
of 3,30-diaminobenzidine. Sections were dehydrated and coverslipped. See
the Supplemental Experimental Procedures for details.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Discussion, Supplemental
Experimental Procedures, seven figures, and six tables and can be found
with this article online at http://dx.doi.org/10.1016/j.celrep.2015.02.009.
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